News

Published on 19 May 2023 on WIVB Buffalo

Buffalo Billion’s Athenex files bankruptcy


Article preview image

Cuomo, through his Buffalo Billion economic development initiative, infused $200 million in subsidies to build Athenex a new manufacturing facility

NASDAQ.IBRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why EV-Maker Mullen Automotive's Stock Is Charging Monday - Mullen Automotive (NASDAQ:MULN)

Mullen Automotive, Inc. MULN shares are trading higher Monday after the company announced the Cal...

Benzinga 29 Apr 2024

What's Going On With Super Micro Computer Stock Ahead Of Earnings? - Super Micro Computer...

Super Micro Computer, Inc. SMCI shares are trading higher Monday, and the stock is up more than 2...

Benzinga 29 Apr 2024

ImmunityBio Drug Gets FDA Nod - Los Angeles Business Journal

Approval clears way for distribution.

Los Angeles Business Journal 29 Apr 2024

ImmunityBio shares target raised on Anktiva pricing strategy By Investing.com

On Monday, ImmunityBio Inc (NASDAQ:IBRX) saw its price target increased by Piper Sandler from $5....

Investing.com 29 Apr 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.40% By Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.40%

Investing.com 26 Apr 2024

What's Going On With ImmunityBio Stock? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio, Inc. IBRX shares are trading higher Friday after the company announced overall survi...

Benzinga 26 Apr 2024

FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies

FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies Monday, the FDA approved ImmunityBi...

Benzinga via Yahoo Finance 23 Apr 2024

ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)

Shares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy ...

Seeking Alpha 23 Apr 2024

ImmunityBio, Inc. (NASDAQ:IBRX): When Will It Breakeven?

We feel now is a pretty good time to analyse ImmunityBio, Inc.'s (NASDAQ:IBRX) business as it app...

Simply Wall St. via Yahoo Finance 13 Feb 2024

ImmunityBio (IBRX)'s Technical Outlook is Bright After Key Golden Cross

ImmunityBio, Inc. (IBRX) reached a significant support level, and could be a good pick for invest...

Zacks via Yahoo Finance 27 Nov 2023